A randomized controlled trial of oseltamivir in outpatients with chronic pulmonary disease: a pilot study

奥司他韦治疗慢性肺病门诊患者的随机对照试验：初步研究

• 批准号: 306099
• 负责人: Loeb Mark B
• 金额: $ 15.87万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-03-01 至 2015-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=306099&lang=en
• 关键词: Clinical Trial; Influenza; Oseltamivir; Respiratory Illness

Patients with chronic disease are at high risk for complications of influenza, including hospitalization, pneumonia, bronchitis, and reduced functional status. Antiviral medications, such as oseltamivir, can be used to treat influenza. However, it is unce

慢性病患者患流感并发症的风险很高，包括住院、肺炎、支气管炎和功能状态下降。抗病毒药物，如奥司他韦，可用于治疗流感。然而，这是unce